Dieter Weinand ’87, Chairman and CEO of Bayer Pharmaceuticals (ret.), was appointed as Chairman of the Board at Meliora Therapeutics, a machine learning therapeutics company developing novel and transformative cancer drugs. Weinand has 30 years of experience in the pharmaceutical industry, including leadership roles at Bayer, Pfizer, Bristol-Myers Squibb, and Sanofi.
